HealthDay on MSN4d
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of ...
Fox Business4d
Eli Lilly's tirzepatide is off the FDA's shortage list: What it means for patients
The Food and Drug Administration (FDA ... of course – that it will push tirzepatide injection back into shortage," he added. McGowan agreed that patients will need to seek alternative ...
JD Supra13d
GLP-1 Drugs: FDA Removes Lilly’s Zepbound® and Mounjaro® (tirzepatide injection) from its Drug Shortage List
On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been “resolved”.
Yorkshire Evening Post10d
Tirzepatide: what is weight loss injection Mounjaro, what have the experts said - how is different to Ozempic?
Nearly 250,000 people in England could access a weight loss injection on the NHS ... Mounjaro, the brand name for tirzepatide, is a drug that treats type 2 diabetes by lowering blood sugar ...
Hosted on MSN3d
Lilly Loses Around $14B This Week: How to Play LLY Stock
The stock of Eli Lilly and Company LLY has declined 1.7% already this week, losing almost $14 billion of its market value.
Health.com5d
What the End of a Tirzepatide Shortage Would Mean for Access to Compounded Weight Loss Drugs
If the FDA were to eventually remove the drug from the shortage list, this would have significant implications for people using tirzepatide or compounded versions of the drugs. Is tirzepatide ...
kjrh.com6d
FDA is reconsidering its decision to take tirzepatide off its drug shortage list
Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications Mounjaro and Zepbound, the Food and Drug Administration said in a recent ...